Evotec SE Share Price Nasdaq
Stocks
EVO
US30050E1055
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
01:30:00 23/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.580 USD | +2.60% |
|
-3.07% | -48.70% |
| 18/09 | Evotec at the top of the SDax - Positive comments at a conference | DP |
| 09/09 | Evotec Initiates Phase 1 Trial of Potential Smallpox, Mpox Treatment | MT |
| Market Cap | 50Cr 57Cr 47Cr 43Cr 80Cr 5.46TCr 80Cr 562.61Cr 217.1Cr 2.79TCr 214.33Cr 209.64Cr 8.98TCr | P/E 2026 * |
-2.39x | P/E 2027 * | -6.52x |
|---|---|---|---|---|---|
| Enterprise Value | 64Cr 73Cr 60Cr 55Cr 103.28Cr 7.02TCr 103.3Cr 723.74Cr 279.27Cr 3.58TCr 275.72Cr 269.68Cr 12TCr | EV / Sales 2026 * |
1.07x | EV / Sales 2027 * | 0.91x |
| Free-Float |
89.91% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| EVO | Delayed | |
CBOE
| EVO | Real-time | |
|
Boerse Muenchen
| EVTA | Real-time | |
|
Deutsche Boerse AG
| EVTA | Delayed | |
|
Börse Stuttgart
| EVTA | Delayed |
Last Transcript: Evotec SE
| 1 day | +2.60% | ||
| 1 week | -3.07% | ||
| Current month | -15.96% | ||
| 1 month | -18.13% | ||
| 3 months | -39.69% | ||
| 6 months | -34.98% | ||
| Current year | -48.70% |
| 1 week | 1.5 |  | 1.75 |
| 1 month | 1.5 | | 1.97 |
| Current year | 1.5 | | 3.87 |
| 1 year | 1.5 | | 4.27 |
| 3 years | 1.5 | | 12 |
| 5 years | 1.5 | | 26.57 |
| 10 years | 1.5 | | 26.57 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 01/07/2024 | |
| Director of Finance/CFO | - | 01/05/2026 | |
Ingrid Müller
COO | Chief Operating Officer | - | 01/05/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Roland Sackers
BRD | Director/Board Member | 58 | 19/06/2019 |
| Director/Board Member | 64 | 01/06/2021 | |
Duncan McHale
BRD | Director/Board Member | 59 | 10/06/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.60% | -3.07% | - | - | 57Cr | |
| +2.55% | +4.77% | +4.07% | +32.02% | 4.67TCr | |
| +0.08% | +0.16% | +43.79% | +35.89% | 4.44TCr | |
| +0.05% | -5.86% | +334.27% | +542.87% | 4.13TCr | |
| +0.66% | +6.23% | +8.96% | +93.14% | 4.16TCr | |
| -1.60% | -0.17% | +9.73% | +43.63% | 3.01TCr | |
| +0.96% | +1.56% | +26.52% | +159.67% | 1.74TCr | |
| -0.01% | -0.92% | - | - | 1.56TCr | |
| +1.15% | +7.46% | +25.97% | +43.93% | 1.55TCr | |
| -1.08% | +12.11% | -10.11% | - | 1.41TCr | |
| Average | +0.57% | +3.39% | +55.40% | +135.88% | 2.96TCr | |
| Weighted average by Cap. | +0.48% | +1.94% | +69.02% | +144.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 60Cr 69Cr 56Cr 52Cr 97Cr 6.57TCr 97Cr 677.8Cr 261.55Cr 3.36TCr 258.22Cr 252.56Cr 11TCr | 72Cr 83Cr 68Cr 62Cr 116.56Cr 7.92TCr 116.58Cr 816.79Cr 315.18Cr 4.05TCr 311.17Cr 304.35Cr 13TCr |
| Net income | -20Cr -23Cr -19Cr -17Cr -33Cr -2.21TCr -33Cr -227.85Cr -88Cr -1.13TCr -87Cr -85Cr -3.64TCr | -4.83Cr -5.52Cr -4.53Cr -4.14Cr -7.77Cr -527.82Cr -7.77Cr -54Cr -21Cr -269.54Cr -21Cr -20Cr -868.96Cr |
| Net Debt | 14Cr 16Cr 13Cr 12Cr 23Cr 1.56TCr 23Cr 161.14Cr 62Cr 798.01Cr 61Cr 60Cr 2.57TCr | 16Cr 19Cr 15Cr 14Cr 26Cr 1.77TCr 26Cr 182.92Cr 71Cr 905.93Cr 70Cr 68Cr 2.92TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/26/22 | $1.580 | +2.60% | 1,26,936 |
| 21/26/21 | $1.540 | -3.75% | 6,85,697 |
| 18/26/18 | $1.600 | -4.19% | 13,78,543 |
| 17/26/17 | $1.670 | +2.45% | 21,495 |
| 16/26/16 | $1.630 | 0.00% | 24,916 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EVT Stock
- EVO Stock
Select your edition
All financial news and data tailored to specific country editions
